Literature DB >> 8952561

The influence of risk factors on breast carcinoma screening of Medicare-insured older women. National Cancer Institute Breast Cancer Screening Consortium.

R Roetzheim1, S A Fox, B Leake, F Houn.   

Abstract

BACKGROUND: It is not certain whether older women with additional breast carcinoma risk factors are adequately screened or whether they are more likely to undergo screening than other older women. This study was conducted to determine whether selected risk factors influence the breast carcinoma screening rates of Medicare-insured older women (i.e., age 65 years or older).
METHODS: Self-reported rates of screening mammography and clinical breast examination in the previous year were compared for women with benign breast disease, women with a family history of breast carcinoma, and women lacking these risks, using samples of non-Hispanic white, Medicare-insured women surveyed at the 5 National Cancer Institute Breast Cancer Screening Consortium sites in 1991 (n = 5376, mean age = 69.7 years) and 1994 (n = 5086, mean age = 69.7 years).
RESULTS: In 1993, rates of screening mammography reported in the previous year at the 5 Consortium sites had a range of 46-61% for women with a family history of breast carcinoma, 49-66% for women with benign breast disease, and 31-43% for women lacking these risks. Women with a positive family history or a personal history of benign breast disease were also more likely to report having had a clinical breast examination in the previous year and having received a physician's mammography recommendation. A substantial proportion of older women with a positive family history remain inadequately screened, however. Between 25% and 35% of women in this group had not had a screening mammogram in the previous 2 years, while at some Consortium sites more than 20% reported never having had a mammogram in their lives.
CONCLUSIONS: Older women with additional risk factors are more likely to undergo screening mammography. This is due partly to more frequent physician recommendations for screening and partly to more frequent provision of clinical breast examinations. However, a substantial proportion of high risk older women remain inadequately screened, despite widespread clinical consensus that these women should be regularly screened. Interventions that target older women with risk factors and their physicians appear warranted. Understanding the mechanisms by which risk factors influence screening is an important area for future research.

Entities:  

Mesh:

Year:  1996        PMID: 8952561     DOI: 10.1002/(sici)1097-0142(19961215)78:12<2526::aid-cncr12>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening?

Authors:  M S O'Malley; J A Earp; S T Hawley; M J Schell; H F Mathews; J Mitchell
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Breast and cervical cancer screening patterns among American Indian women at IHS clinics in Montana and Wyoming.

Authors:  Robin Taylor Wilson; Jennifer Giroux; Kathryn Rita Kasicky; Bethany Hemlock Fatupaito; Eric C Wood; Renee Crichlow; Neil A Sun Rhodes; Jennifer Tingueley; Andrea Walling; Kathryn Langwell; Nathaniel Cobb
Journal:  Public Health Rep       Date:  2011 Nov-Dec       Impact factor: 2.792

3.  Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.

Authors:  S Lemon; J Zapka; E Puleo; R Luckmann; L Chasan-Taber
Journal:  Am J Public Health       Date:  2001-08       Impact factor: 9.308

4.  Targeted mailed materials and the Medicare beneficiary: increasing mammogram screening among the elderly.

Authors:  S A Fox; J A Stein; R J Sockloskie; M G Ory
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

5.  Screening practice and misplaced priorities.

Authors:  Davide Mauri; Antonis Valachis; Nikolaos P Polyzos; Ivan Cortinovis; Vassiliki Karampoiki; Evridiki Loukidou; Paraskevi Alevizaki; Konstantinos Kamposioras; Georgios Kouris; Parthenopi Alexandropoulou; Lamprini Tsali; Charalampos Panou; Athanasios Stamatelopoulos; Velisarios Lakiotis; Anastasia Spiliopoulou; Aikaterini Terzoudi; Aliki Ioakimidou; Ioanna Karathanasi; Magdalini Bristianou; Giovanni Casazza; Nicholas Pavlidis
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.